127927-Thumbnail Image.png

Recent outbreaks of Zika virus (ZIKV) highlight the urgent need to develop efficacious interventions against flaviviruses, many of which cause devastating epidemics around the world. Monoclonal antibodies (mAb) have been…

Recent outbreaks of Zika virus (ZIKV) highlight the urgent need to develop efficacious interventions against flaviviruses, many of which cause devastating epidemics around the world. Monoclonal antibodies (mAb) have been at the forefront of treatment for cancer and a wide array of other diseases due to their specificity and potency.

Copyright Statement
    • Reuse Permissions
    • application/pdf

    Original

    Download count: 0

    Details

    Contributors
    Date Created
    • 2017-12-25
    Resource Type
  • Text
    • Collections this item is in
    ASU Scholarship Showcase
    Identifier
    • Digital object identifier: 10.3390/ijms19010054
    • International standard serial number
      1661-6596
    • International standard serial number
      1422-0067

    Citation and reuse

    Cite this item

    This is a suggested citation. Consult the appropriate style guide for specific citation guidelines.

    Sun, H., Chen, Q., & Lai, H. (2017). Development of Antibody Therapeutics against Flaviviruses. International Journal of Molecular Sciences, 19(1), 54. doi:10.3390/ijms19010054

    Machine-readable links